We need to talk about Vivek
The one-time DOGE disciple looks ahead to Columbus.
Vivek Ramaswamy won the Republican primary for Ohio governor without much drama. The spectacle had already happened elsewhere, neatly paving a pathway to Columbus. Recall the not-too-distant 2024 presidential debates, the cable hits, the book-tour fluency, the tech-bro cadences, the happy-warrior confidence of a man who seems to have learned politics from the internet and capital allocation from a pitch deck. By the time Ohio Republicans formally made him their nominee, the novelty had already worn a little smooth. And yet, what do we know about this plausible next governor of Ohio?
Meantime, Amy Acton, the former Ohio health director whose daily pandemic briefings made her one of the most recognizable public officials in the state, won the Democratic nomination uncontested.
So the field is set: Acton, the physician-administrator associated with public-health caution and the grim wariness of 2020 in America, against Ramaswamy, the biotech entrepreneur and anti-bureaucratic insurgent.
It is tempting to describe this as another Trump-era culture-war race, and it is that, at least in part. But Ramaswamy is not merely a Trump understudy with better diction and a Yale Law degree. He represents something more specific, which is the arrival of venture-capital governance as a leading philosophy for a large Midwestern state.
That phrase, VC governance, can sound like seminar-room fog until you listen to him for a few minutes, until you consider broader trends already reshaping the mold for up-and-coming candidates in both major parties.
Ramaswamy talks about government the way a founder might talk about an aging company acquired at a discount. The systems are bloated and the incentives are broken. He insists that the assets are underperforming, though he’s short on specifics, however vaguely accurate his basic point may be. The answer, as ever, is a gesture toward restructuring, simple and clean.
This is not the old Ohio Republicanism of George Voinovich, John Kasich, or Mike DeWine, men who, whatever their limits and politics, generally treated public institutions as things that should go on existing. Good riddance in a way. But Ramaswamy speaks a different dialect; institutions in his worldview are not presumed to be civic goods. They are systems that must prove their efficiency and utility, must prove a viable ROI.
That distinction matters because Ohio is nothing if not a state of aging systems. We are ripe as a target for this sort of message.
Consider the landscape. We are a state of regional universities, Medicaid networks, hospitals, county agencies, transit systems, long-term-care infrastructure, public schools, water utilities, bridges, municipal governments. These are not glamorous institutions, and many of them are not especially beloved. They are expensive, imperfect, bureaucratic. They are often slow in anything they carry out. They are also the machinery through which millions of people live their daily lives.
Across Ohio, much of that machinery already operates under strain. The state is older than it used to be. Its college-age population is shrinking, and enrollment is down generally. Hospitals face labor shortages and reimbursement pressure. Local governments stretch aging infrastructure across tax bases that do not grow like the Sun Belt. The systems still function, mostly. But they function with the distinct modern feeling of being asked to do more with less while everyone yells at them for the way they do it.
Into that atmosphere steps Ramaswamy, whose campaign has made a theme of this institutional excess.
At a campaign stop in northwest Ohio, in a video posted by his own campaign, Ramaswamy said he wanted Ohio to have “the best universities,” but added, “We have too many of them. They need to be consolidated.” He argued that consolidation would allow schools to become “centers of excellence” instead of “replicas and clones of one another throughout the state.” The comment touched a nerve among higher-education leaders, especially at regional campuses already living with budget pressure, enrollment decline, and the sinking suspicion that the next decade will be less generous than the last one.
His campaign later insisted he was not proposing to eliminate Ohio’s universities, but rather to cut bureaucracy and strengthen higher education, backing his way out of specific political policy views and into the vagaries of campaign promises. Ramaswamy has argued, clearly, that Ohio faces a severe enrollment cliff. In a campaign-published column, he noted that Ohio’s number of high school graduates peaked around 2024 and is projected to fall significantly by 2041. The problem he identifies is real. The proposed instinct is what matters here. How should the state respond? This is but one Major Question posed by the governor’s race this year.
The universities, in his telling, are not first civic anchors, social-mobility engines, research centers, commuter campuses, workforce pipelines, or even regional stabilizers. They are a fragmented system that endlessly duplicates functions. They carry overhead. They need consolidation.
It is a small window into a larger way of seeing.
Everyone needs an origin story
Before politics, before the presidential debates, before the performative skirmishes over wokeness and bureaucracy, Ramaswamy came out of biotech finance.
In 2014, he founded Roivant Sciences, a pharmaceutical holding company built around an unusually financialized approach to drug development. Instead of operating like a traditional pharmaceutical company built primarily around long-horizon internal research, Roivant specialized in acquiring or licensing overlooked drug candidates, often from larger drug companies, and placing them into separate subsidiaries. These companies often carried the now-famous suffix: “vant.”
The model was clever, modern, and perfectly suited to an era in which capital wanted speed, narrative, and optionality: Find the neglected asset, repackage it, build a company around it, raise money, move fast, break stuff as needed.
The most famous and controversial of these companies was Axovant Sciences. (What I’m describing here is all very well known, though my hunch is that the average Ohio voter doesn’t know about Axovant or, really, about Vivek Ramaswamy at all.)
